Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,978.00
(
0.12%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
103.82
(
3.13%
)
Bitcoin
67,796.00
(
-1.44%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RexRowdy post# 3779

Tuesday, 09/28/2004 10:55:05 AM

Tuesday, September 28, 2004 10:55:05 AM

Post# of 257295
>> Can anything about the progress of the other phase 2 clinical trials be deduced by virtue of the fact that GENR has started the last phase 2 trial? <<

I don’t think so. The real issue is why it took this long (six months) to start the combo trial. I think the delay was probably caused by a combination of the protocol change (adding the 10mg dose) and supply constraints.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today